Akebia Therapeutics, Inc. (AKBA)
1.21
-0.15
(-11.03%)
USD |
NASDAQ |
Feb 13, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Profit Margin (Quarterly) : 0.92% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 13.47% |
| Pfizer Inc. | -9.34% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -5.49% |
| Return on Invested Capital | -7.86% |
| Gross Profit Margin (Quarterly) | 83.49% |
| Operating Margin (Quarterly) | 7.57% |
| Return on Net Operating Assets | -11.03% |